ArticlePlant physiology2025
Benzoic and salicylic acids inhibit β-substituted alanine synthase 4;1 in common bean.
Article in Plant physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decoding plant metabolism.Plant physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The nutritionally essential sulfur amino acids, methionine and cysteine, are present at suboptimal levels in legumes, such as common bean (Phaseolus vulgaris L.). β-Substituted alanine synthase 4;1 (BSAS4;1) is the major isoform of cytosolic cysteine synthase present in the developing seeds of common bean. There is evidence that in addition to cysteine, this enzyme is also involved in the biosynthesis of the non-proteinogenic amino acid S-methylcysteine, which accumulates in the form of a γ-glutamyl dipeptide. Here, we report the high-resolution structure of recombinant BSAS4;1. Unexpectedly, the crystal structure showed the presence of a molecule of benzoic acid near the active site, which appeared to have been co-purified from Escherichia coli. Kinetic analysis indicated that benzoic acid acts as a competitive inhibitor of BSAS4;1 with respect to O-acetylserine. IC50 values for benzoic acid and the structurally related salicylic acid were both equal to 0.6 mm. Using developing cotyledons grown in vitro, quantification of the incorporation of 13C3- and 15N-labeled serine into cysteine and downstream metabolites indicated that benzoic acid effectively inhibited cysteine biosynthesis in vivo at a concentration of 1.2 mm. The results of experiments tracking the incorporation of 13C-labeled sodium thiomethoxide provided further evidence that BSAS4;1 may be involved in the formation of free S-methylcysteine, through the condensation of O-acetylserine with methanethiol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.